|
Volumn 104, Issue 12, 2009, Pages 3100-3101
|
Helicobacter pylori eradication, endoscopic surveillance, and gastric cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CAGA PROTEIN;
GASTRIN;
PEPSINOGEN I;
ANTIINFECTIVE AGENT;
BIOTECHNOLOGY;
CANCER RISK;
CANCER SURVIVAL;
EARLY DIAGNOSIS;
ENDOSCOPY;
ERADICATION THERAPY;
FOLLOW UP;
GENETIC POLYMORPHISM;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HIGH RISK POPULATION;
HIGH THROUGHPUT SCREENING;
HUMAN;
LETTER;
MOLECULAR GENETICS;
NARROW BAND IMAGING;
PRECANCER;
PRIORITY JOURNAL;
PROTEOMICS;
RISK ASSESSMENT;
RISK FACTOR;
STOMACH CANCER;
STOMACH CARCINOGENESIS;
STOMACH CARCINOMA;
SURVIVAL TIME;
ADENOCARCINOMA;
ADULT;
BIOPSY;
DRUG EFFECT;
FEMALE;
GASTRECTOMY;
GASTROINTESTINAL ENDOSCOPY;
ISOLATION AND PURIFICATION;
MALE;
MICROBIOLOGY;
MIDDLE AGED;
NOTE;
PATHOLOGY;
STOMACH MUCOSA;
STOMACH TUMOR;
TIME;
ADENOCARCINOMA;
ADULT;
ANTI-BACTERIAL AGENTS;
BIOPSY;
EARLY DIAGNOSIS;
ENDOSCOPY, GASTROINTESTINAL;
FEMALE;
GASTRECTOMY;
GASTRIC MUCOSA;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
MALE;
MIDDLE AGED;
RISK FACTORS;
STOMACH NEOPLASMS;
TIME FACTORS;
|
EID: 72949124440
PISSN: 00029270
EISSN: 15720241
Source Type: Journal
DOI: 10.1038/ajg.2009.514 Document Type: Letter |
Times cited : (5)
|
References (6)
|